Quantum BioPharma Ltd. 提交 11 月 Form 6-K 外国私人发行人报告
6-K - Quantum Biopharma Ltd. (0001771885) (Filer)
Quantum BioPharma Ltd. 向美国证券交易委员会提交了 Form 6-K 外国私人发行人报告,报告月份为 11 月。文件由首席财务官 Donal Carroll 于 11 月 5 日签署,并列有一份同日新闻稿作为附件。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2026
Commission File Number: 001-39152
Quantum BioPharma Ltd.
(Translation of registrant's name into English)
1 Adelaide Street East, Suite 801
Toronto, Ontario M5C 2V9
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Quantum BioPharma Ltd. | ||
| (Registrant) | ||
| Date: November 5, 2026 | /s/ Donal Carroll | |
| Donal Carroll | ||
| Chief Financial Officer | ||
EXHIBIT INDEX
| Exhibit Number | Description | |
| 99.1 | Press Release dated November 5, 2026 |
来源:SEC EDGAR · 本站存档